Advances in the Diagnosis and Treatment of Barrett's Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium

J Gastrointest Surg. 2017 Aug;21(8):1342-1349. doi: 10.1007/s11605-017-3390-5. Epub 2017 Feb 27.

Abstract

Background: Patients with Barrett's esophagus (BE) are at increased risk of developing esophageal adenocarcinoma (EAC). The incidence of EAC is rising faster than any other cancer.

Discussion: Patients with BE have a 30- to 40-fold increased risk of EAC. In the past 20 years, there have been dramatic advances in our understanding of the incidence and natural history of BE. Endoscopic treatment of BE is evolving. Even early EAC has been treated without esophagectomy and good oncologic results in the modern era.

Keywords: Barrett’s esophagus; Early esophageal adenocarcinoma.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma* / diagnosis
  • Adenocarcinoma* / pathology
  • Adenocarcinoma* / therapy
  • Barrett Esophagus* / diagnosis
  • Barrett Esophagus* / pathology
  • Barrett Esophagus* / therapy
  • Early Detection of Cancer
  • Esophageal Neoplasms* / diagnosis
  • Esophageal Neoplasms* / pathology
  • Esophageal Neoplasms* / therapy
  • Esophagectomy
  • Esophagoscopy
  • Humans
  • Neoplasm Staging